SureAdhere for Behavioral Health
Patients seeking opioid use disorder treatment through Medication Assisted Treatment (MAT) with methadone or buprenorphine often face significant obstacles to remain engaged and committed to care. These challenges include the cost of travel, difficulty allocating time for treatment, and even social stigma toward people with Opioid Use Disorder (OUD).
SureAdhere addresses these challenges by providing patients the flexibility and convenience of receiving therapy through virtual means while facilitating a continuous feedback loop with a MAT provider when required.
Improve Treatment Access
Increase access to MAT by overcoming traditional barriers to treatment retention, especially for rural and underserved communities and those facing one or more social determinants of health.
Lower Treatment Burden
Overcome traditional time, cost, and travel burdens associated with in-person MAT through secure and reliable remote treatment support.
Increase Autonomy
Empower patients to become actively engaged in recovery by increasing personal autonomy through robust digital engagement.
Globally Recognised
Over 350 Public Health programs across the US, Europe & Asia use SureAdhere. SureAdhere complies with US HIPAA and European GDPR data privacy regulations, and our global support team provides comprehensive service level agreements based on local time zones.
VOT for MOUD in Vermont
Due to the heavy logistical burden of accessing MAT, nearly half of all patients enrolled in outpatient MAT programs in Vermont disengage with treatment before 1 year. In response to this concerning trend, the Howard Center in Burlington, Vermont developed and implemented a pilot VOT intervention - "Wheels and Waves" - aimed to address the challenges faced by patients when accessing MAT. Wheels and Waves paired a secure medication dispenser with recorded VOT to support daily methadone and suboxone adherence. The Howard Center also offered patient support mechanisms via text, voice, and in-person visits when missed doses or patient concerns were reported.
Wheels and Waves drastically reduced the time, cost, and travel burden on those enrolled in the intervention. In total, patients saved a median of $72 per week on travel costs and an average of 5.5 hours per week of travel time to the clinic.
The pilot also saw 93% of patients engaging in pro-social activities like going to work, school, and visiting family. Retention in care was nearly double what it was for the standard of care in Vermont - going from 45% of patients engaged in treatment after 1 year to 98% of patients enrolled in the pilot still engaged after 1 year.
*Brooklyn, John R et al. “Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment.” Journal of Addiction Medicine, 2022;16(3):310-316
The median weekly savings on travel costs.
Weekly clinic travel time saved on average
Retention in care dramatically improved, from 45% to 98% compared to the standard of care in Vermont, and 93% of patients engaged in pro-social activities after just one year.
Results from the ‘Wheels and Waves’ intervention designed and implemented by the Howard Center
Our Partners in Behavioral Health
Publications & Research
The Vermont Care Network/Vermont Care Partners 'Wheels and Waves' Program - Treating Opioid Use Disorder with Video Directly Observed Therapy (VDOT)
Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment